Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection

Clinical and Applied Thrombosis/Hemostasis

Volumn 18, Issue 6, 2012, Pages 569-575

  Davenport, Daniel L ^a   Vargas, H David ^a   Kasten, Michael W ^a   Xenos, Eleftherios S ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

clinical thrombophilia; deep venous thrombosis; hypercoagulability; pulmonary embolism; thrombophilia; venous thromboembolism

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; STEROID;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CARDIOVASCULAR RISK; CHRONIC DISEASE; COLORECTAL CANCER; COLORECTAL SURGERY; DEEP VEIN THROMBOSIS; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; STEROID THERAPY; SURGICAL PATIENT; SURGICAL RISK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RISK FACTORS; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84868521483     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611433642     Document Type: Article

References (30)

1. Warwick D, Friedman RJ, Agnelli G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: Findings from the Global Orthopaedic Registry. J Bone Joint Surg Br. 2007 ; 89 (6). 799-807 (Pubitemid 47180202)
2. Planes A, Vochelle N, Darmon JY, Fagola M, Bellaud M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet. 1996 ; 348 (9022). 224-228 (Pubitemid 26254196)
3. Geerts WH, Bergqvist D, Pineo GF, et al. American College of Chest Physicians Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest. 2008 ; 133 (6 suppl). 381S - 453S (Pubitemid 351894916)
4. Galster H, Kolb G, Kohsytorz A, Seidlmayer C, Paal V. The pre-, peri-, and postsurgical activation of coagulation and the thromboembolic risk for different risk groups. Thromb Res. 2000 ; 100 (5). 381-388 (Pubitemid 32056969)
5. Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg. 1998 ; 228 (4). 491-507 (Pubitemid 30194393)
6. Khuri SF, Daley J, Henderson W, et al. Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg. 1997 ; 185 (4). 315-327
7. Wun T, White R. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Invest. 2009 ; 27 (suppl 1). 63-74
8. Otten HM, Mathijssen J, ten Cate H, et al. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy. Arch Intern Med. 2004 ; 164 (2). 190-194 (Pubitemid 38140406)
9. Bergqvist D. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery. Br J Surg. 2004 ; 91 (8). 965-974 (Pubitemid 39070809)
10. Kakkar AK, Cohen AT, Tapson VF, et al. ENDORSE Investigators Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg. 2010 ; 251 (2). 330-338
11. Muntz J. Duration of deep vein thrombosis prophylaxis in the surgical patient and its relation to quality issues. Am J Surg. 2010 ; 200 (3). 413-421
12. Stender MT, Nielsen TS, Frokjaer JB, Larsen TB, Lundbye-Christensen S, Thorlacius-Ussing O. High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer. Br J Surg. 2007 ; 94 (9). 1100-1103 (Pubitemid 350082855)
13. McNally M, Burns C. Venous thromboembolic disease in colorectal patients. Clin Colon Rectal Surg. 2009 ; 22 (1). 34-40
14. Bergqvist D, Agnelli G, Cohen A, et al. for ENOXACAN II Investigators Duration of prohylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med. 2002 ; 346 (13). 975-980 (Pubitemid 34983247)
15. Wun T, White RH. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Invest. 2009 ; 27 (suppl 1). 63-74
16. Iversen L, Thorlacius-Ussing O, Okholm M. Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease. Thromb Res. 1995 ; 79 (5-6). 471-481
17. Alcalay A, Wun T, Khatri V, et al. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol. 2006 ; 24 (7). 1112-1118 (Pubitemid 46638808)
18. Al Diab AI. Cancer-related venous thromboembolism: insight into underestimated risk factors. Hematol Oncol Stem Cell Ther. 2010 ; 3 (4). 191-195
19. Okines A, Cunningham D. Current perspective: Bevacizumab in colorectal cancer-a time for reappraisal?. Eur J Cancer. 2009 ; 45 (14). 2452-2461
20. Roddy JV, Partridge SM, Rockey ML, Pruemer JM, Guo JJ, Desai SJ. Thromboembolic events in patients with colorectal cancer receiving the combination of bevacizumab-based chemotherapy and erythropoietin stimulating agents. Am J Clin Oncol. 2010 ; 33 (1). 36-42
21. Fleming FJ, Kim MJ, Salloum RM, Young KC, Monson JR. How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database. Dis Colon Rectum. 2010 ; 53 (10). 1355-1360
22. Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. PREVENT Medical Thromboprophylaxis Study Group Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004 ; 110 (7). 874-879 (Pubitemid 39096017)
23. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006 ; 243 (1). 89-95 (Pubitemid 43054059)
24. Yu HT, Dylan ML, Lin J, Dubois RW. Hospitals' compliance with prophylaxis guidelines for venous thromboembolism. Am J Health Syst Pharm. 2007 ; 64 (1). 69-76 (Pubitemid 46395711)
25. Amin AN, Stemkowski S, Lin J, Yang G. Preventing venous thromboembolism in US hospitals: are surgical patients receiving appropriate prophylaxis?. Thromb Haemost. 2008 ; 99 (4). 796-797 (Pubitemid 351694244)
26. Polk HC, McCafferty MH, Mahid SS, Naidu DK, Lewis JN. Attitudes of surgical specialists toward venous thromboembolism prophylaxis in surgical patients. Am Surg. 2008 ; 74 (3). 189-194 (Pubitemid 351323695)
27. Rahme E, Dasgupta K, Burman M, et al. Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery. CMAJ. 2008 ; 178 (12). 1545-1554 (Pubitemid 351860340)
28. Rasmussen MS, Jorgensen LN, Wille-Jorgensen P, Nielsen JD, Horn A, Mohn AC. the FAME Investigators Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study. J Thromb Haemost. 2006 ; 4 (11). 2384-2390 (Pubitemid 44575433)
29. Kaatz S, Spyropoulos AC. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care. Hosp Pract (Minneap). 2011 ; 39 (3). 7-15
30. Huo MH, Muntz J. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Clin Ther. 2009 ; 31 (6). 1129-1141